Literature DB >> 24131052

Studying the role of ApoE in Alzheimer's disease pathogenesis using a systems biology model.

Christina Rose Kyrtsos1, John S Baras.   

Abstract

Alzheimer's disease (AD) is the most common form of dementia. Even with its well-known symptoms of memory loss and well-characterized pathology of beta amyloid (Aβ) plaques and neurofibrillary tangles, the disease pathogenesis and initiating factors are still not well understood. To tackle this problem, a systems biology model has been developed and used to study the varying effects of variations in the ApoE allele present, as well as the effects of short term and periodic inflammation at low to moderate levels. Simulations showed a late onset peak of Aβ in the ApoE4 case that lead to localized neuron loss which could be ameliorated in part by application of short-term pro-inflammatory mediators. The model that has been developed herein represents one of the first attempts to model AD from a systems approach to study physiologically relevant parameters that may prove useful to physicians in the future.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24131052     DOI: 10.1142/S0219720013420031

Source DB:  PubMed          Journal:  J Bioinform Comput Biol        ISSN: 0219-7200            Impact factor:   1.122


  5 in total

1.  Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E.

Authors:  Angana Ray; Navjeet Ahalawat; Jagannath Mondal
Journal:  Biophys J       Date:  2017-12-19       Impact factor: 4.033

Review 2.  The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future Directions.

Authors:  A Lloret-Villas; T M Varusai; N Juty; C Laibe; N Le NovÈre; H Hermjakob; V Chelliah
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-01-07

Review 3.  Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).

Authors:  Mubashir Hassan; Qamar Abbas; Sung-Yum Seo; Saba Shahzadi; Hany Al Ashwal; Nazar Zaki; Zeeshan Iqbal; Ahmed A Moustafa
Journal:  Mol Med Rep       Date:  2018-05-22       Impact factor: 2.952

Review 4.  Bridging Scales in Alzheimer's Disease: Biological Framework for Brain Simulation With The Virtual Brain.

Authors:  Leon Stefanovski; Jil Mona Meier; Roopa Kalsank Pai; Paul Triebkorn; Tristram Lett; Leon Martin; Konstantin Bülau; Martin Hofmann-Apitius; Ana Solodkin; Anthony Randal McIntosh; Petra Ritter
Journal:  Front Neuroinform       Date:  2021-04-01       Impact factor: 4.081

Review 5.  Impact of Caffeine on Alzheimer's Disease Pathogenesis-Protective or Risk Factor?

Authors:  Thomas Gabriel Schreiner; Bogdan Ovidiu Popescu
Journal:  Life (Basel)       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.